The ELISA mouse TNFRI (TNFRSF1A) test quantified the presence of mouse TNFRI in serum, plasma, or cell culture media. The dosage will recognize only natural and recombinant Ms STNFRI. Principle of...
The ELISA mouse TNFRI (TNFRSF1A) test quantified the presence of mouse TNFRI in serum, plasma, or cell culture media. The dosage will recognize only natural and recombinant Ms STNFRI. Method Principle The ELISA solid phase sandwich test for mouse TNFRI (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
TNFR1 (Tumoral Necrosis Factor 1 receptor) belongs to the tumour necrosis factor superfamily and is one of the major TNF-alpha receptors. TNFR1 plays an important role in mediation, cytokine-mediated signaling, positive regulation of the NF-Kb pathway, positive regulation of angiogenesis, and negative regulation of genetic expression. The extracellular domain of TNFR1 is also released into the circulatory system as soluble TNFR1 (sTNFR1). In humans, the TNFR1 gene is found on chromosome 12. It has been shown that l-athanogen 4 in combination with anti-apoptotic protein BCL2 (BAG4/SODD) and adaptive proteins TRADD and TRAF2 interact with TNFR1 and thus play regulatory roles in transduction of the receptor-mediated signal. Germinal mutations in extracellular areas of TNFR1 have been associated with dominant autosomal periodic fever syndrome, and clearance of altered receptors is considered a mechanism of disease.
Sensitivity
Sensitivity of the dosage: 1 pg/ml.
Measurement range
Dose range: 1.23 to 300 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Volume of sample: Plasma, 20 µl; serum, 20 µl; supernatant, 50 µl.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17145789 |
| Specifications |
| Accession number | CD120a; CD120a antigen; FPF; hypothetical protein; COL100346106; MGC19588; MS5; activation factor n-SMASE; p55; receiver p55 TNF; p55-R; p60; P62; p63; SCD120a; soluble CD120a; soluble TNFR1; STNF RI; sTNFR I; sTNFR1; sTNFRI; TBP1; TBPI; alpha string of TNF receiver; member of the |
| Dose range | 1.23 to 300 pg/ml |
| Sensitivity of the dosage | 1 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P25118 |
| Gene symbol(s) | Tnfrsf1a |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96-well pre-coated plate Standard Concentrate of dosing diluent Biotinylated detection antibody SAV-HRP Wash pad Chromogen Discontinue solution Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | TNFR1 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 20 µl; serum, 20 µl; supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EMTNFRSF1AX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.